Peripheral Vascular and Endovascular recruiting and talent strategy.
Peripheral work is split across vascular surgery, interventional cardiology and interventional radiology, and the same procedure may sit in a hospital lab or an office based lab depending on the market. Catheters, stents and grafts demand precise engineering, clinical trials and regulatory work, and the field carries a wide device bag. R&D, clinical, regulatory and commercial teams all have to serve physicians who treat the same disease differently.
- Placing peripheral vascular and endovascular talent
- 7 yearsPlacing peripheral vascular and endovascular talent
- Placements made
- 3,500+Placements made
- We search, listed below
- 5 areasWe search, listed below
Inside peripheral vascular and endovascular.
A search usually sits in one of these areas, and often spans two or three.
Peripheral artery disease
Treatment of claudication and critical limb ischemia with balloons, stents, atherectomy and crossing devices, from the iliac arteries down to the pedal vessels. Device design for specific lesion types, clinical trial evidence and being present with the right inventory all shape case-by-case choice.
- Catheter Design Engineer
- Clinical Trial Manager
- Clinical Specialist
- Territory Manager
Aortic disease
Endovascular repair of abdominal and thoracic aneurysms and dissections, including branched and fenestrated grafts, alongside open surgical graft repair. Sizing and planning happen off CT before the case, so graft engineering, imaging and planning software and field clinical engineers carry the work.
- Graft Design Engineer
- Imaging Analyst
- Field Clinical Engineer
- Aortic Sales Specialist
Venous disease
Superficial venous ablation, sclerotherapy and adhesive closure for varicose veins, plus deep venous stenting for iliofemoral obstruction. Superficial work often happens in physician owned clinics, so energy and material development, clinical education and practice economics all matter.
- R&D Engineer
- Clinical Educator
- Practice Development Manager
- Market Access Manager
Thrombectomy and embolectomy
Mechanical and aspiration thrombectomy for pulmonary embolism, deep vein thrombosis and acute limb ischemia. Cases are unscheduled and often run through a pulmonary embolism response team, so device engineering, clinical evidence, call coverage and training a rotating group of physicians all count.
- Product Development Engineer
- Clinical Affairs Manager
- Clinical Specialist
- Therapy Development Manager
Vascular access and closure
Introducer sheaths, radial and femoral access products, and the closure devices and compression bands used to achieve hemostasis at the end of a case. These are high volume consumables, so manufacturing cost, quality and supply reliability matter alongside conversions and staff familiarity.
- Manufacturing Engineer
- Quality Engineer
- Clinical Educator
- Strategic Account Manager
Where peripheral vascular and endovascular searches go wrong.
The assumptions that cost the most time, and what tends to be true instead.
“Coronary talent moves into peripheral without much of a learning curve”
The catheter skills carry, but the customer and the anatomy don't. Peripheral decisions sit with vascular surgeons, interventional radiologists and cardiologists who may treat the same disease differently, and long, calcified lesions behave differently from coronary work. That applies to engineers and clinical staff as much as to the field team.
“Office based lab selling is the same job as hospital selling”
In a hospital the work runs through value analysis, contracts and a service line budget. An office based lab puts the physician in the owner's seat, and the conversation covers reimbursement per procedure, inventory carried on the shelf and staffing. Commercial hires who have only sold through committees often stall when the buyer is also the operator.
“One leader can run arterial, venous, aortic and thrombectomy as a single business”
Peripheral portfolios behave like separate businesses, with different physicians, evidence needs, engineering platforms and call patterns. Leadership teams that manage all of it as one tend to fund the predictable scheduled lines and underinvest in the emergent and complex ones. Separate product, clinical and commercial ownership usually works better.
“The most experienced candidate in the therapy area is the safest hire.”
Most companies default to the most experienced candidate, assuming experience equals execution. Early-stage and growth-stage MedTech needs builders, not maintainers, and those are rarely the same person.
Morgan Mills, Senior Talent Director
Individual contributors to executive leadership.
The same vertical knowledge applies across commercial, clinical, R&D and engineering, regulatory, quality and operations, whether the seat is in the field, the lab, the plant or the boardroom.
- Executive
- Sales
- Marketing
- Clinical
- Regulatory
- Quality
- R&D
- Engineering
- Operations
- National Accounts
- Market Access
Four steps, every time.
The same sequence whether the seat is an engineer, a clinical lead or a territory in peripheral vascular and endovascular, or the executive who builds the team around them.
- 01Define
A Talent Director who knows your specialty scopes the role, what it has to deliver and the profile that actually wins in your market.
- 02Search & vet
We reach passive candidates others can't, then screen for skill, culture fit and motivation before you see a single resume.
- 03Present
Three to five qualified, interested candidates with our written assessment. Interviews are coordinated for you.
- 04Close & onboard
Offer strategy, counter-offer prep and a 90-day check-in so great hires become long-term ones.
Two ways to work with us in peripheral vascular and endovascular.
Next door to this vertical.
- Why peripheral vascular companies keep hiring for relationships over ability, and what the best-athlete hiring model looks like in practiceMorgan Mills
- How total compensation in peripheral vascular MedTech has shifted over the past three years, and what the numbers mean for how companies should build their teams nowMorgan Mills
- Why clinical validation is now a commercial strategy decision in cardiovascular and peripheral vascular MedTech, and what happens to adoption when it is treated as an afterthoughtMorgan Mills
- What actually drives EV/EBITDA multiples in cardiovascular and vascular MedTech, and why most founders and operators optimize for the wrong things before a raise or exitMorgan Mills
- The vascular and cardiovascular talent marketNatalie Johnson
Filling seats isn't the objective. The business outcome is.
Tell us what this hire needs to make possible.
We'll bring you the peripheral vascular and endovascular market before we bring you a shortlist.